This article discusses President Joe Biden's efforts to lower prescription drug costs in the United States. It highlights the high prices Americans pay for prescription drugs compared to other countries and the struggles many face in affording their medications. The article mentions Executive Order 14036, which aimed to improve competition and reduce prices for prescription drugs. It also mentions the Inflation Reduction Act of 2022, signed into law by President Biden, which will lower the cost of prescription drugs for Medicare beneficiaries by implementing caps on out-of-pocket costs and requiring certain companies to pay Medicare rebates for price increases. The article states that the Department of Health and Human Services (HHS) has taken steps to swiftly implement these provisions. Additionally, the article discusses the role of the Center for Medicare and Medicaid Innovation in testing new health care payment and delivery models to lower drug costs and promote access to innovative drug therapies. The Secretary of HHS is directed to consider selecting these models and submit a report on the selected models and a plan for testing them. The article concludes with general provisions, stating that the order does not impair existing authorities or create new rights or benefits.